Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Other 1Genitourinary 1

Conditions

Urinary Incontinence 4Prostatic Neoplasms 4Rectal Neoplasms 2Neoplasms 2Sexual Dysfunction, Physiological 1Prostatic Hyperplasia 1Pancreatic Neoplasms 1Motor Activity 1Low Anterior Resection Syndrome 1Intestinal Diseases 1Hemiplegia 1Fecal Incontinence 1Colonic Neoplasms 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 92Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 52Doxorubicin 50trametinib 47atezolizumab 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Biofeedback, Psychology × Clear all
NCT03692624 2020-03-06

Use of Heart Rate Variability (HRV) Biofeedback for Cancer Survivors

Prisma Health-Upstate

Phase NA Completed
34 enrolled
Tumor-Agnostic

Neoplasms

NCT00632138 2013-08-07

Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate

National Cancer Institute (NCI)

Phase 3 Completed
800 enrolled
GenitourinaryOther

Neoplasms, Prostatic Hyperplasia, Prostatic Neoplasms, Sexual Dysfunction, Physiological, Urinary Incontinence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡